United States of America (Press Release) May 14, 2008 --
NICE NEWS for ACOMPLIA! SLIMONA! RIMONABANT!
Britain’s National Institute for Health and Clinical Excellence has given approval for Rimonabant (Acomplia, Slimona).
PARIS, March 08- French drug maker Sanofi-Aventis (said on Wednesday that its obesity-fighting product Rimonabant (Acomplia) had won approval from Britain's National Institute for Health and Clinical Excellence (NICE).
NICE had recommended that Rimonabant (Acomplia, Slimona) should be made available for the management of obese and overweight patients on the UK's state-run National Health Service.
The British government has made fighting obesity, particularly among young people, one of its key priorities.
Britain’s National Institute for Health and Clinical Excellence has given approval for Rimonabant (Acomplia, Slimona).
PARIS, March 08- French drug maker Sanofi-Aventis (said on Wednesday that its obesity-fighting product Rimonabant (Acomplia) had won approval from Britain's National Institute for Health and Clinical Excellence (NICE).
NICE had recommended that Rimonabant (Acomplia, Slimona) should be made available for the management of obese and overweight patients on the UK's state-run National Health Service.
The British government has made fighting obesity, particularly among young people, one of its key priorities.

The British government has made fighting obesity, particularly among young people, one of its key priorities. Purchase Acomplia Rimonabant a new wonder drug for weight loss online.
Email
Print
SPAM
LEAVE A COMMENT





